N-[4-(2-bromo-11,11-dimethylindeno[1,2-b]carbazol-5-yl)phenyl]-N-phenylnaphthalen-2-amine
C43H31BrN2 — CID 66585323
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(2-bromo-11,11-dimethylindeno[1,2-b]carbazol-5-yl)phenyl]-N-phenylnaphthalen-2-amine
N-[4-(2-bromo-11,11-dimethylindeno[1,2-b]carbazol-5-yl)phenyl]-N-phenylnaphthalen-2-amine (PubChem CID 66585323) has the molecular formula C43H31BrN2 and a molecular weight of 655.64 g/mol. Its IUPAC name is N-[4-(2-bromo-11,11-dimethylindeno[1,2-b]carbazol-5-yl)phenyl]-N-phenylnaphthalen-2-amine.
Molecular Properties
| Compound Name | N-[4-(2-bromo-11,11-dimethylindeno[1,2-b]carbazol-5-yl)phenyl]-N-phenylnaphthalen-2-amine |
|---|---|
| PubChem CID | 66585323 |
| Molecular Formula | C43H31BrN2 |
| Molecular Weight | 655.64 g/mol |
| Exact Mass | 654.17 |
| IUPAC Name | N-[4-(2-bromo-11,11-dimethylindeno[1,2-b]carbazol-5-yl)phenyl]-N-phenylnaphthalen-2-amine |
| SMILES | CC1(C)c2ccccc2-c2cc3c(cc21)c1cc(Br)ccc1n3-c1ccc(N(c2ccccc2)c2ccc3ccccc3c2)cc1 |
| InChI | InChI=1S/C43H31BrN2/c1-43(2)39-15-9-8-14-35(39)36-27-42-38(26-40(36)43)37-25-30(44)17-23-41(37)46(42)33-21-19-32(20-22-33)45(31-12-4-3-5-13-31)34-18-16-28-10-6-7-11-29(28)24-34/h3-27H,1-2H3 |
| InChIKey | HCYHZQPKCGGFLI-UHFFFAOYSA-N |
| XLogP | 12.48 |
| TPSA | 8.17 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 655.64 |
| LogP ≤ 5 | 12.48 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 66585323 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.